Ipecac-induced myopathy simulating dermatomyositis

Harvey Bennett, Alfred J. Spiro, Michael A. Pollack, Preston Zucker

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

We studied a young woman with an eating disorder. To induce vomiting, she took syrup of ipecac daily for 2 years, and then developed insidious, progressive muscle weakness. Skin findings were similar to those of dermatomyositis. Muscle biopsy, however, was similar to experimental emetine myopathy and lacked inflammatory features. Upon cessation of ipecac abuse, strength returned. We believe that this patient had ipecac-induced muscle weakness.

Original languageEnglish (US)
Pages (from-to)91-94
Number of pages4
JournalNeurology
Volume32
Issue number1
StatePublished - Jan 1 1982
Externally publishedYes

Fingerprint

Ipecac
Dermatomyositis
Muscular Diseases
Muscle Weakness
Emetine
Myositis
Vomiting
Biopsy
Muscles
Skin

All Science Journal Classification (ASJC) codes

  • Clinical Neurology

Cite this

Bennett, H., Spiro, A. J., Pollack, M. A., & Zucker, P. (1982). Ipecac-induced myopathy simulating dermatomyositis. Neurology, 32(1), 91-94.
Bennett, Harvey ; Spiro, Alfred J. ; Pollack, Michael A. ; Zucker, Preston. / Ipecac-induced myopathy simulating dermatomyositis. In: Neurology. 1982 ; Vol. 32, No. 1. pp. 91-94.
@article{cbee30394c67464d8d9518250a2fb74e,
title = "Ipecac-induced myopathy simulating dermatomyositis",
abstract = "We studied a young woman with an eating disorder. To induce vomiting, she took syrup of ipecac daily for 2 years, and then developed insidious, progressive muscle weakness. Skin findings were similar to those of dermatomyositis. Muscle biopsy, however, was similar to experimental emetine myopathy and lacked inflammatory features. Upon cessation of ipecac abuse, strength returned. We believe that this patient had ipecac-induced muscle weakness.",
author = "Harvey Bennett and Spiro, {Alfred J.} and Pollack, {Michael A.} and Preston Zucker",
year = "1982",
month = "1",
day = "1",
language = "English (US)",
volume = "32",
pages = "91--94",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

Bennett, H, Spiro, AJ, Pollack, MA & Zucker, P 1982, 'Ipecac-induced myopathy simulating dermatomyositis', Neurology, vol. 32, no. 1, pp. 91-94.

Ipecac-induced myopathy simulating dermatomyositis. / Bennett, Harvey; Spiro, Alfred J.; Pollack, Michael A.; Zucker, Preston.

In: Neurology, Vol. 32, No. 1, 01.01.1982, p. 91-94.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Ipecac-induced myopathy simulating dermatomyositis

AU - Bennett, Harvey

AU - Spiro, Alfred J.

AU - Pollack, Michael A.

AU - Zucker, Preston

PY - 1982/1/1

Y1 - 1982/1/1

N2 - We studied a young woman with an eating disorder. To induce vomiting, she took syrup of ipecac daily for 2 years, and then developed insidious, progressive muscle weakness. Skin findings were similar to those of dermatomyositis. Muscle biopsy, however, was similar to experimental emetine myopathy and lacked inflammatory features. Upon cessation of ipecac abuse, strength returned. We believe that this patient had ipecac-induced muscle weakness.

AB - We studied a young woman with an eating disorder. To induce vomiting, she took syrup of ipecac daily for 2 years, and then developed insidious, progressive muscle weakness. Skin findings were similar to those of dermatomyositis. Muscle biopsy, however, was similar to experimental emetine myopathy and lacked inflammatory features. Upon cessation of ipecac abuse, strength returned. We believe that this patient had ipecac-induced muscle weakness.

UR - http://www.scopus.com/inward/record.url?scp=0020042135&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020042135&partnerID=8YFLogxK

M3 - Article

C2 - 6119651

AN - SCOPUS:0020042135

VL - 32

SP - 91

EP - 94

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 1

ER -

Bennett H, Spiro AJ, Pollack MA, Zucker P. Ipecac-induced myopathy simulating dermatomyositis. Neurology. 1982 Jan 1;32(1):91-94.